Visual Field Quality Control in the Ocular Hypertension Treatment Study (OHTS)
暂无分享,去创建一个
Chris A Johnson | Chris A. Johnson | Juanjuan Fan | Mae O Gordon | Richard A Levine | M. Kass | M. Gordon | J. Keltner | John L Keltner | Michael A Kass | Kimberly E Cello | Shannan E Bandermann | K. Cello | R. Levine | J. Fan | S. E. Bandermann | K. E. Cello | Juanjuan Fan
[1] Chris A. Johnson,et al. Visual field profile of optic neuritis. One-year follow-up in the Optic Neuritis Treatment Trial. , 1995, Archives of ophthalmology.
[2] Chris A. Johnson,et al. The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma. , 2002, Archives of ophthalmology.
[3] G. Trick,et al. Assessing the utility of reliability indices for automated visual fields. Testing ocular hypertensives. , 1989, Ophthalmology.
[4] Michael Wall,et al. High- and low-risk profiles for the development of multiple sclerosis within 10 years after optic neuritis: experience of the optic neuritis treatment trial. , 2003, Archives of ophthalmology.
[5] Chris A. Johnson,et al. Visual Field Profile of Optic Neuritis: One-Year Follow-up in the Optic Neuritis Treatment Trial , 1994 .
[6] C A Johnson,et al. Quality control functions of the Visual Field Reading Center (VFRC) for the Optic Neuritis Treatment Trial (ONTT). , 1993, Controlled clinical trials.
[7] Chris A. Johnson,et al. CONFIRMATION OF VISUAL FIELD ABNORMALITIES IN THE OCULAR HYPERTENSION TREATMENT STUDY (OHTS) , 1999 .
[8] M. Wall,et al. Effect of instructions on conventional automated perimetry. , 2000, Investigative ophthalmology & visual science.
[9] M. Kass,et al. The Ocular Hypertension Treatment Study: design and baseline description of the participants. , 1999, Archives of ophthalmology.
[10] Chris A. Johnson,et al. The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma. , 2002 .
[11] D. Shin,et al. Analysis of reliability indices from Humphrey visual field tests in an urban glaucoma population. , 1997, Ophthalmology.
[12] E. E. Hartmann,et al. The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. , 2002, Archives of ophthalmology.
[13] R. Beck,et al. Baseline visual field profile of optic neuritis. The experience of the optic neuritis treatment trial. Optic Neuritis Study Group. , 1993, Archives of ophthalmology.
[14] Chris A Johnson,et al. Baseline visual field characteristics in the ocular hypertension treatment study. , 2002, Ophthalmology.
[15] Chris A Johnson,et al. Classification of visual field abnormalities in the ocular hypertension treatment study. , 2000, Archives of ophthalmology.
[16] J L Keltner,et al. Confirmation of visual field abnormalities in the Ocular Hypertension Treatment Study. Ocular Hypertension Treatment Study Group. , 2000, Archives of ophthalmology.
[17] M. Brodsky,et al. Visual function more than 10 years after optic neuritis: experience of the optic neuritis treatment trial. , 2004, American journal of ophthalmology.